主要组织相容性复合体
抗原呈递
MHC I级
细胞毒性T细胞
肿瘤微环境
抗原
MHC II级
生物
MHC限制
癌症研究
T细胞
抗原提呈细胞
免疫学
抗原处理
细胞生物学
免疫系统
体外
遗传学
作者
Anne M. Macy,Lauren M Herrmann,Anngela C. Adams,Karen Taraszka Hastings
标识
DOI:10.1016/j.coi.2023.102330
摘要
Major histocompatibility complex class-II-restricted presentation by nonprofessional antigen-presenting cells in the tumor microenvironment can regulate antitumor T-cell responses. In murine models, tumor cell-specific MHC class II expression decreases in vivo tumor growth, dependent on T cells. Tumor cell-specific MHC class II expression is associated with improved survival and response to immune checkpoint inhibitors in human cancers. Antigen-presenting cancer-associated fibroblasts (apCAF) present MHC class-II-restricted antigens and activate CD4 T cells. The role of MHC class II on apCAFs depends on the cell of origin. MHC class II on tumoral lymphatic endothelial cells leads to expansion of regulatory T cells and increased in vivo tumor growth.
科研通智能强力驱动
Strongly Powered by AbleSci AI